Axa’s Morgan Stanley Emerging Mkts Fd MSF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-70,000
| Closed | -$1.13M | – | 1434 |
|
|
2018
Q4 | $1.13M | Hold |
70,000
| – | – | ﹤0.01% | 945 |
|
|
2018
Q3 | $1.09M | Hold |
70,000
| – | – | ﹤0.01% | 1017 |
|
|
2018
Q2 | $1.14M | Hold |
70,000
| – | – | ﹤0.01% | 976 |
|
|
2018
Q1 | $1.29M | Hold |
70,000
| – | – | 0.01% | 944 |
|
|
2017
Q4 | $1.25M | Hold |
70,000
| – | – | ﹤0.01% | 948 |
|
|
2017
Q3 | $1.22M | Hold |
70,000
| – | – | 0.01% | 922 |
|
|
2017
Q2 | $1.13M | Hold |
70,000
| – | – | 0.01% | 908 |
|
|
2017
Q1 | $1.03M | Hold |
70,000
| – | – | ﹤0.01% | 922 |
|
|
2016
Q4 | $923K | Hold |
70,000
| – | – | ﹤0.01% | 920 |
|
|
2016
Q3 | $1.02M | Hold |
70,000
| – | – | ﹤0.01% | 897 |
|
|
2016
Q2 | $930K | Hold |
70,000
| – | – | ﹤0.01% | 890 |
|
|
2016
Q1 | $923K | Hold |
70,000
| – | – | ﹤0.01% | 887 |
|
|
2015
Q4 | $900K | Hold |
70,000
| – | – | ﹤0.01% | 933 |
|
|
2015
Q3 | $885K | Hold |
70,000
| – | – | ﹤0.01% | 933 |
|
|
2015
Q2 | $1.04M | Hold |
70,000
| – | – | ﹤0.01% | 953 |
|
|
2015
Q1 | $1.04M | Hold |
70,000
| – | – | ﹤0.01% | 936 |
|
|
2014
Q4 | $1.02M | Hold |
70,000
| – | – | ﹤0.01% | 945 |
|
|
2014
Q3 | $1.08M | Hold |
70,000
| – | – | ﹤0.01% | 886 |
|
|
2014
Q2 | $1.12M | Hold |
70,000
| – | – | ﹤0.01% | 898 |
|
|
2014
Q1 | $1.07M | Hold |
70,000
| – | – | ﹤0.01% | 907 |
|
|
2013
Q4 | $1.08M | Hold |
70,000
| – | – | ﹤0.01% | 910 |
|
|
2013
Q3 | $1.05M | Hold |
70,000
| – | – | 0.01% | 864 |
|
|
2013
Q2 | $1M | Buy |
+70,000
| New | +$1.08M | 0.01% | 838 |
|
Other funds holding MSF
Axa's MSF Position: Q1 2019 in Review
Axa sold out of Morgan Stanley Emerging Mkts Fd (MSF) in Q1 2019, closing a stake of 70,000 shares — an estimated $1.13M sold.
Axa first reported a position in MSF in Q2 2013 and held it in 23 quarters. The position peaked at $1.29M in Q1 2018. 1 fund tracked by Wall St. Rank holds MSF as of Q1 2019.
- Axa reported no remaining Morgan Stanley Emerging Mkts Fd position as of Q1 2019 after selling out during the quarter.
- Axa sold 70,000 Morgan Stanley Emerging Mkts Fd shares in Q1 2019, an estimated $1.13M.
- Axa first reported a position in Morgan Stanley Emerging Mkts Fd in Q2 2013 and held it in 23 quarters.
- Axa's Morgan Stanley Emerging Mkts Fd position peaked at $1.29M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Morgan Stanley Emerging Mkts Fd as of Q1 2019.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.